Business ❯ Biotechnology

Acquisitions

Pharmaceuticals Mergers and Acquisitions Company Sales Curevac Gene Editing Corporate Transactions Gilead Sciences Investment Genmab Data Privacy Mergers Eli Lilly Corporate Strategy Johnson & Johnson

Eli Lilly to Acquire Orna Therapeutics in Up to $2.4 Billion Bet on In Vivo CAR‑T

The deal gives Lilly Orna’s circular RNA–LNP platform to generate cell therapies inside patients.

Pfizer Wins Metsera With $10 Billion Cash‑Plus‑CVR Offer as Novo Withdraws

Genmab to Buy Merus for $8 Billion to Secure Petosemtamab Cancer Drug

Roche to Acquire 89bio in Deal Worth Up to $3.5 Billion

Kite Pharma to Buy Interius for $350 Million, Adding In‑Vivo CAR‑T Platform

Sanofi Signs $1.15 Billion Deal to Acquire Vicebio’s Molecular Clamp Respiratory Vaccine Platform

Eli Lilly to Acquire Verve Therapeutics for $1.3 Billion